GlassScriptPhysician profile
Angelica E Honsberg
NPI 1508899253
$3,695.33
in general payments reported to CMS, 2019-2025
22 companies · $746 in 2025
The $746 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $385 · 2020: $390 · 2021: $589 · 2022: $747 · 2023: $326 · 2024: $513 · 2025: $746.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,546 · Education: $39.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,545.74 |
| Education | $39.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $686.12 | 2019-2023 | Bronchitol, Pertzye |
| Abbvie INC. | $403.95 | 2020-2025 | |
| Vertex Pharmaceuticals Incorporated | $398.66 | 2019-2025 | |
| Nestle Healthcare Nutrition INC. | $349.18 | 2020-2023 | |
| Digestive Care, INC. | $259.39 | 2024-2025 | Pertzye |
| Astrazeneca Pharmaceuticals LP | $239.64 | 2024-2025 | Tezspire, Fasenra |
| Aimmune Therapeutics, INC. | $227.88 | 2024-2025 | Zenpep |
| Gilead Sciences, INC. | $222.28 | 2019-2022 | |
| Mylan Specialty L.P. | $155.83 | 2020-2022 | |
| Insmed, INC. | $133.86 | 2019-2025 | Arikayce |
| Electromed, INC. | $110.01 | 2024-2025 | Smartvest |
| Tactile Systems Technology INC | $107.81 | 2022-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Allergan, INC. | $97.85 | 2019-2020 | |
| Advanced Respiratory, INC | $83.41 | 2020-2021 | |
| Glaxosmithkline, LLC. | $51.08 | 2023-2025 | Nucala |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcresta Therapeutics, INC. | $31.44 | 2025 | Relizorb |
| Merck Sharp & Dohme LLC | $30.41 | 2022-2023 | Recarbrio, Zerbaxa |
| Baxter Healthcare | $28.04 | 2024 | Hillrom - Monarch Airway Clearance System |
| Regeneron Healthcare Solutions, INC. | $26.95 | 2025 | Dupixent |
| Dexcom, INC. | $23.83 | 2025 | Dexcom G6 Transmitter |
| Genentech USA, INC. | $14.17 | 2023 | Pulmozyme |
| Inogen, INC. | $13.54 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angelica Honsberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.